NEWS

• Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity

  Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome Development (DECODE) in Obesity.

• Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture

  Quotient Sciences announced a new partnership with the UK CPI (Centre for Process Innovation) to help accelerate mRNA therapeutics — combining CPI capabilities in LNP manufacturing and technology with Quotient Sciences' clinical and drug product development platform, Translational Pharmaceutics®.

• Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights

  In a move set to redefine how biotech and biopharma sponsors plan and launch clinical trials, Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies, has partnered with Ryght AI & to bring advanced, AI-driven feasibility capabilities to biotech and biopharma sponsors.

• PCM Trials, EmVenio Research, And Clinical Trial Service Rebrand As EmVenio Clinical Research

  EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator to improve access for trial participants.

• CORE 2025 - October 6-8, 2025

  CORE 2025 brings together leaders across biotech, pharma, regulatory agencies, and digital health to define the future of clinical development, scale innovation into operational excellence, and foster industry-wide alignment.

• Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift

  Crucial Data Solutions (CDS), provider of the industry’s only end-to-end eClinical platform available as a native mobile app, today announced that Leigh J. Mack, MD, PhD has rejoined the company as Chief Medical Officer. Dr. Mack, who previously served in this role from 2017 to 2021, brings renewed focus to aligning artificial intelligence (AI) with the future of regulatory compliance and clinical trial execution.

• ISPOR Champions Research Transparency With Launch Of Open Science Badges

  ISPOR has introduced an initiative to recognize transparency in research for papers published in Value in Health, its preeminent HEOR journal.

• Introducing Arcinova, A Quotient Sciences Company

  Arcinova offers solutions tailored for early development, from candidate selection through to proof of concept. This means faster, more efficient development pathways, deeper scientific expertise and expanded access to specialized services to help you bring innovative therapies to patients sooner.

• November 9-12: ISPOR Europe 2025: Powering Value And Access Through Patient-Centered Collaboration

  This year’s theme emphasizes the importance of strengthening partnerships across the healthcare ecosystem to accelerate patient-centered decision-making on healthcare value and access.

• September 28-30: ISPOR Real-World Evidence Summit 2025: Through The Lens Of Asia Pacific

  The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

• September 10-11: Communicating HEOR For Maximum Impact, Influence, And Understanding

  Master the art of communicating HEOR evidence to diverse audiences. This course equips participants with tools to communicate their work clearly and effectively, ensuring its relevance and value are understood.

• Quotient Sciences Announces Formation Of Scientific Advisory Board

  Quotient Sciences, a leading integrated CRDMO (contract research, development and manufacturing organization) for the pharmaceutical and biotech industry, is pleased to announce the formation of its Scientific Advisory Board (SAB) and appointment of inaugural members from the US, UK and Europe.

• Meet Avance Clinical At 2025 KoNECT-MOHW-MFDS International Conference (KIC)

  This prestigious conference is a premier platform for biotech and pharma companies to explore emerging trends, regulatory developments, and innovations shaping the future of clinical trials across Asia and around the world.

• Meet Avance Clinical At BIO Asia-Taiwan 2025

  This year’s program features Business Partnering, Exhibitions, and Conferences, offering insights into emerging bio-health trends, technologies, and global expansion strategies. Our team is looking forward to connecting with biotech leaders in Taiwan to discuss tailored solutions across the drug development lifecycle.